tiprankstipranks
CSL Share Price Decline Continues, Here’s Why
PremiumGlobal MarketsCSL Share Price Decline Continues, Here’s Why
3M ago
Half year reported NPATA US$2 billion¹,² Up 13% at constant currency³
PremiumPress Releases
Half year reported NPATA US$2 billion¹,² Up 13% at constant currency³
3M ago
Half year reported NPATA US$2 billion¹,² Up 13% at constant currency³
PremiumPress Releases
Half year reported NPATA US$2 billion¹,² Up 13% at constant currency³
3M ago
Arcturus Therapeutics, CSL publish data on booster dose of ARCT-154
PremiumThe FlyArcturus Therapeutics, CSL publish data on booster dose of ARCT-154
5M ago
CSL upgraded to Conviction Buy from Buy at Goldman Sachs
PremiumThe Fly
CSL upgraded to Conviction Buy from Buy at Goldman Sachs
5M ago
CSL’s and Arcturus Therapeutics’ mRNA vaccine for COVID approved in Japan
PremiumThe Fly
CSL’s and Arcturus Therapeutics’ mRNA vaccine for COVID approved in Japan
5M ago
CSL Seqirus begins shipping portfolio of flu vaccines for 2023/24 U.S. season
PremiumThe FlyCSL Seqirus begins shipping portfolio of flu vaccines for 2023/24 U.S. season
10M ago
CSL says first patient receives FDA-approved HEMGENIX in U.S.
PremiumThe Fly
CSL says first patient receives FDA-approved HEMGENIX in U.S.
11M ago
CSL Share Price: Is Now the Time to Grab More of This ASX Giant?
PremiumGlobal Markets
CSL Share Price: Is Now the Time to Grab More of This ASX Giant?
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100